You are here: Home » Current Affairs » Coronavirus » News
Business Standard

Centre orders 660 mn Covishield doses, to be supplied by Dec: Report

The Union government has placed a purchase order with the Serum Institute of India (SII) for 66 crore doses of Covishield to be supplied by December, official sources said on Thursday.

Coronavirus Vaccine | Serum Institute of India | Health Ministry

Press Trust of India  |  New Delhi 

India too had opened diplomatic dialogues with the European Union (EU) after the EU Digital Covid Certificate framework recognised the AstraZeneca-Oxford vaccine, but not Covishield.

The Union government has placed a purchase order with the (SII) for 66 crore doses of Covishield to be supplied by December, official sources said on Thursday.

The development comes after Prakash Kumar Singh, the Director, Government and Regulatory Affairs at SII, informed the Union that the firm would be able to supply 20.29 crore doses of Covishied in the month of September.

The Pune-based firm has enhanced the manufacturing capacity of Covishield to more than 20 crore doses per month.

The had in July placed an order with Bharat Biotech for the supply of 28.50 crore doses of Covaxin, but the firm has not been able to start the supply of those yet, an official source said.

Bharat Biotech is close to completing the supply of five crore doses of Covaxin for which the had placed an order on March 12, the source said.

The source added that the ministry had placed an order for 37.50 crore doses of Covishield between August to December and the SII is going to complete this suppl by mid-September.

On August 31, as the cumulative COVID-19 vaccine doses administered in the country crossed the 65-crore mark, Singh in his communication to NITI Aayog member (Health) Dr V K Paul and Union Health Secretary Rajesh Bhushan had mentioned that SII alone has supplied more than 60 crore doses of Covishield

Of these 60 crore doses, 2.1 crore were provided in January, 2.5 crore in February, over 4.73 crore in March, more than 6.25 crore in April, over 5.96 crore in May, more than 9.68 crore in June, over 12.37 crore in July and more than 16.92 crore in August, he had said.

In May, Singh had written a letter to Union Home Minister Amit Shah mentioning that its employees have been working round the clock in spite of various challenges because of the pandemic.

"We are pleased to inform that in the month of June we will be able to manufacture and supply nine to 10 crore doses of our Covishield vaccine to the country as compared to our production capacity of 6.5 crore doses in May," he had said in the letter.

"has always been sincerely concerned about the protection of the citizens of our country and world at large from COVID-19. Under the leadership of our CEO, Adar C Poonawalla, our team have been working relentlessly shoulder to shoulder with our government to fight the COVID-19 pandemic," he had said.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Thu, September 09 2021. 19:08 IST